Annual Report 2025
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group, year ended 31 December 2025 | 2024Group, year ended 31 December 2024 (restated) | Source |
|---|---|---|---|
| Income statement | |||
| Salesmillion CHF | 6,531 | 5,480 | PDF p. 34 |
| Cost of goods soldmillion CHF | (4,222) | (3,687) | PDF p. 34 |
| Gross profitmillion CHF | 2,309 | 1,793 | PDF p. 34 |
| Marketing and distributionmillion CHF | (190) | (186) | PDF p. 34 |
| Research and developmentmillion CHF | (112) | (102) | PDF p. 34 |
| Administration and general overheadsmillion CHF | (726) | (599) | PDF p. 34 |
| Other operating incomemillion CHF | 24 | 106 | PDF p. 34 |
| Other operating expensesmillion CHF | (66) | (104) | PDF p. 34 |
| Result from operating activities (EBIT)million CHF | 1,239 | 908 | PDF p. 34 |
| Financial incomemillion CHF | 67 | 64 | PDF p. 34 |
| Financial expensesmillion CHF | (207) | (263) | PDF p. 34 |
| Net financial resultmillion CHF | (140) | (199) | PDF p. 34 |
| Share of profit / (loss) of associates / joint venturesmillion CHF | 2 | (1) | PDF p. 34 |
| Profit before income taxesmillion CHF | 1,101 | 708 | PDF p. 34 |
| Income taxesmillion CHF | (192) | (106) | PDF p. 34 |
| Profit from continuing operationsmillion CHF | 909 | 602 | PDF p. 34 |
| Profit / (Loss) from discontinued operations, net of taxmillion CHF | (1,184) | 35 | PDF p. 34 |
| Profit / (Loss) for the periodmillion CHF | (275) | 637 | PDF p. 34 |
| Attributable to | |||
| Equity holders of the parentmillion CHF | (275) | 636 | PDF p. 34 |
| Non-controlling interestmillion CHF | 0 | 1 | PDF p. 34 |
| EPS for profit from continuing operations attributable to equity holders of the parent | |||
| Basic earnings per share – EPS basicCHF per share | 13.04 | 8.51 | PDF p. 34 |
| Diluted earnings per share – EPS dilutedCHF per share | 13.00 | 8.49 | PDF p. 34 |
| EPS for profit / (loss) attributable to equity holders of the parent | |||
| Basic earnings per share – EPS basicCHF per share | (3.93) | 8.93 | PDF p. 34 |
| Diluted earnings per share – EPS dilutedCHF per share | (3.92) | 8.92 | PDF p. 34 |
Original report: PDF p. 34 ↗
For the year ended 31 December.
See the accompanying notes to the consolidated financial statements.
Restated to reflect the classification of the Capsule and Health Ingredients business as discontinued operations (see notes 1 and 4 of the Group's consolidated financial statements).
Cost of goods sold includes net impairments of CHF 39 million (2024: CHF 59 million) and restructuring income of CHF 6 million (2024: CHF 11 million cost), as well as acquisition related expenses (2025: CHF 7 million, 2024: CHF 143 million).
Administration and general overheads includes the amortization of acquisition related intangible assets (2025: CHF 47 million, 2024: CHF 34 million). Additionally, includes impairments of CHF 46 million (2024: CHF 16 million), acquisition related expenses (2025: CHF 5 million, 2024: CHF 23 million) and business transformation initiative expenses (2025: 53 CHF million, 2024: CHF 14 million).
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group, year ended 31 December 2025 | 2024Group, year ended 31 December 2024 | Source |
|---|---|---|---|
| Statement of comprehensive income | |||
| Profit / (Loss) for the periodmillion CHF | (275) | 637 | PDF p. 34 |
| Items that will not be reclassified to profit or loss | |||
| Remeasurements of net defined benefit liabilitymillion CHF | 139 | (34) | PDF p. 34 |
| Income tax on items that will not be reclassified to profit or lossmillion CHF | (22) | 5 | PDF p. 34 |
| Subtotalmillion CHF | 117 | (29) | PDF p. 34 |
| Items that are or may be reclassified subsequently to profit or loss | |||
| Exchange differences on translating foreign operationsmillion CHF | (555) | 298 | PDF p. 34 |
| Cash flow hedges – effective portion of changes in fair valuemillion CHF | 89 | (105) | PDF p. 34 |
| Cash flow hedges – reclassified to property, plant and equipmentmillion CHF | 6 | 8 | PDF p. 34 |
| Cash flow hedges – reclassified to goodwillmillion CHF | 0 | 35 | PDF p. 34 |
| Cash flow hedges – reclassified to profit or lossmillion CHF | (35) | 32 | PDF p. 34 |
| Cash flow hedges – costs of hedgingmillion CHF | (46) | (29) | PDF p. 34 |
| Income tax on items that are or may be reclassified to profit or lossmillion CHF | 10 | (10) | PDF p. 34 |
| Subtotalmillion CHF | (531) | 229 | PDF p. 34 |
| Statement of comprehensive income | |||
| Other comprehensive income for the period, net of taxmillion CHF | (414) | 200 | PDF p. 34 |
| Total other comprehensive income for the periodmillion CHF | (689) | 837 | PDF p. 34 |
| Total comprehensive income attributable to | |||
| Equity holders of the parentmillion CHF | (684) | 834 | PDF p. 34 |
| Non-controlling interestsmillion CHF | (5) | 3 | PDF p. 34 |
| Total comprehensive income for the periodmillion CHF | (689) | 837 | PDF p. 34 |
Original report: PDF p. 34 ↗
For the year ended 31 December.
See the accompanying notes to the consolidated financial statements.
Unlabelled rows are printed subtotals for the preceding tax line (items not reclassified / items that are or may be reclassified).
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group, at 31 December 2025 | 2024Group, at 31 December 2024 | Source |
|---|---|---|---|
| Assets - Non-current assets | |||
| Property, plant and equipmentmillion CHF | 8,304 | 8,532 | PDF p. 33 |
| Intangible assetsmillion CHF | 328 | 2,002 | PDF p. 33 |
| Goodwillmillion CHF | 1,960 | 3,370 | PDF p. 33 |
| Employee benefit assetsmillion CHF | 108 | 0 | PDF p. 33 |
| Other non-current assetsmillion CHF | 278 | 336 | PDF p. 33 |
| Deferred tax assetsmillion CHF | 95 | 53 | PDF p. 33 |
| Total non-current assetsmillion CHF | 11,073 | 14,293 | PDF p. 33 |
| Assets - Current assets | |||
| Inventoriesmillion CHF | 1,680 | 1,727 | PDF p. 33 |
| Trade receivablesmillion CHF | 1,062 | 1,283 | PDF p. 33 |
| Current tax receivablesmillion CHF | 44 | 44 | PDF p. 33 |
| Other receivables, prepaid expenses and accrued income, incl. derivativesmillion CHF | 678 | 675 | PDF p. 33 |
| Short-term investmentsmillion CHF | 0 | 600 | PDF p. 33 |
| Cash and cash equivalentsmillion CHF | 719 | 1,111 | PDF p. 33 |
| Assets held for salemillion CHF | 2,651 | 0 | PDF p. 33 |
| Total current assetsmillion CHF | 6,834 | 5,440 | PDF p. 33 |
| Assets | |||
| Total assetsmillion CHF | 17,907 | 19,733 | PDF p. 33 |
| Equity and liabilities - Equity | |||
| Share capitalmillion CHF | 70 | 72 | PDF p. 33 |
| Share premiummillion CHF | 1,171 | 1,813 | PDF p. 33 |
| Treasury sharesmillion CHF | (220) | (773) | PDF p. 33 |
| Retained earnings and reservesmillion CHF | 6,892 | 8,216 | PDF p. 33 |
| Total equity attributable to equity holders of the parentmillion CHF | 7,913 | 9,328 | PDF p. 33 |
| Non-controlling interestsmillion CHF | 53 | 60 | PDF p. 33 |
| Total equitymillion CHF | 7,966 | 9,388 | PDF p. 33 |
| Equity and liabilities - Liabilities | |||
| Non-current provisionsmillion CHF | 449 | 434 | PDF p. 33 |
| Employee benefit liabilitiesmillion CHF | 5 | 56 | PDF p. 33 |
| Other non-current liabilitiesmillion CHF | 1,682 | 1,541 | PDF p. 33 |
| Non-current debtmillion CHF | 3,876 | 4,242 | PDF p. 33 |
| Deferred tax liabilitiesmillion CHF | 304 | 493 | PDF p. 33 |
| Total non-current liabilitiesmillion CHF | 6,316 | 6,766 | PDF p. 33 |
| Current provisionsmillion CHF | 79 | 89 | PDF p. 33 |
| Other current liabilitiesmillion CHF | 2,034 | 2,415 | PDF p. 33 |
| Trade payablesmillion CHF | 514 | 471 | PDF p. 33 |
| Current debtmillion CHF | 309 | 468 | PDF p. 33 |
| Current tax payablesmillion CHF | 153 | 136 | PDF p. 33 |
| Liabilities held for salemillion CHF | 536 | 0 | PDF p. 33 |
| Total current liabilitiesmillion CHF | 3,625 | 3,579 | PDF p. 33 |
| Total liabilitiesmillion CHF | 9,941 | 10,345 | PDF p. 33 |
| Equity and liabilities | |||
| Total equity and liabilitiesmillion CHF | 17,907 | 19,733 | PDF p. 33 |
Original report: PDF p. 33 ↗
At 31 December.
See the accompanying notes to the consolidated financial statements.
Assets held for sale related to the Capsules and Health Ingredients business and other immaterial businesses (see note 4.2).
Liabilities held for sale related to the Capsules and Health Ingredients business and other immaterial businesses (see note 4.2).
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Company (Lonza Group Ltd), year 2025 | 2024Company (Lonza Group Ltd), year 2024 | Source |
|---|---|---|---|
| Income | |||
| Dividend incomemillion CHF | 514 | 0 | PDF p. 76 |
| Royalty incomemillion CHF | 39 | 33 | PDF p. 76 |
| Other financial incomemillion CHF | 219 | 223 | PDF p. 76 |
| Other operating incomemillion CHF | 68 | 4 | PDF p. 76 |
| Total incomemillion CHF | 840 | 260 | PDF p. 76 |
| Expenses | |||
| Other financial expensesmillion CHF | 216 | 232 | PDF p. 76 |
| Personnel expensesmillion CHF | 56 | 49 | PDF p. 76 |
| Other operating expensesmillion CHF | 39 | 31 | PDF p. 76 |
| Impairment losses on investmentsmillion CHF | 1,634 | 0 | PDF p. 76 |
| Impairment losses on loansmillion CHF | 82 | 77 | PDF p. 76 |
| Depreciation on equipmentmillion CHF | 0 | 0 | PDF p. 76 |
| Direct taxesmillion CHF | (5) | 2 | PDF p. 76 |
| Total expensesmillion CHF | 2,021 | 391 | PDF p. 76 |
| Result | |||
| (Loss) for the yearmillion CHF | (1,181) | (131) | PDF p. 76 |
Original report: PDF p. 76 ↗
Full impairment of loans to subsidiaries Octane Biotech Inc. & Lonza Technology Holdings, Inc. in 2025, and to the Bacthera AG JV in 2024 (footnote 1 to Impairment losses on loans).
Financial statements are presented in million CHF.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Company (Lonza Group Ltd), at 31 December 2025 | 2024Company (Lonza Group Ltd), at 31 December 2024 | Source |
|---|---|---|---|
| Assets - Current assets | |||
| Cash and cash equivalentsmillion CHF | 599 | 881 | PDF p. 75 |
| Assets - Current assets - Short-term financial assets | |||
| – from third partiesmillion CHF | 134 | 779 | PDF p. 75 |
| – from subsidiaries and associatesmillion CHF | 896 | 1,810 | PDF p. 75 |
| Assets - Current assets - Other short-term receivables | |||
| – from third partiesmillion CHF | 2 | 3 | PDF p. 75 |
| – from subsidiaries and associatesmillion CHF | 102 | 25 | PDF p. 75 |
| Assets - Current assets - Prepaid expenses and accrued income | |||
| – from third partiesmillion CHF | 15 | 12 | PDF p. 75 |
| – from subsidiaries and associatesmillion CHF | 16 | 21 | PDF p. 75 |
| Assets - Current assets | |||
| Total current assetsmillion CHF | 1,764 | 3,531 | PDF p. 75 |
| Assets - Non-current assets - Long-term financial assets | |||
| – from third partiesmillion CHF | 34 | 25 | PDF p. 75 |
| – from subsidiaries and associatesmillion CHF | 4,485 | 3,892 | PDF p. 75 |
| Assets - Non-current assets | |||
| Investmentsmillion CHF | 4,377 | 6,011 | PDF p. 75 |
| Property, plant and equipmentmillion CHF | 0 | 0 | PDF p. 75 |
| Assets - Non-current assets - Prepaid expenses and accrued income | |||
| – from third partiesmillion CHF | 3 | 4 | PDF p. 75 |
| Assets - Non-current assets | |||
| Total non-current assetsmillion CHF | 8,899 | 9,932 | PDF p. 75 |
| Assets | |||
| Total assetsmillion CHF | 10,663 | 13,463 | PDF p. 75 |
| Liabilities - Current liabilities - Trade accounts payables | |||
| – to third partiesmillion CHF | 9 | 16 | PDF p. 75 |
| – to subsidiaries and associatesmillion CHF | 4 | 7 | PDF p. 75 |
| Liabilities - Current liabilities - Short-term interest-bearing liabilities | |||
| – to third partiesmillion CHF | 159 | 451 | PDF p. 75 |
| – to subsidiaries and associatesmillion CHF | 1,294 | 1,347 | PDF p. 75 |
| Liabilities - Current liabilities - Short-term financial liabilities | |||
| – to third partiesmillion CHF | 52 | 125 | PDF p. 75 |
| – to subsidiaries and associatesmillion CHF | 211 | 201 | PDF p. 75 |
| Liabilities - Current liabilities - Short-term provisions | |||
| – to third partiesmillion CHF | 7 | 8 | PDF p. 75 |
| Liabilities - Current liabilities - Accrued expenses and deferred income | |||
| – to third partiesmillion CHF | 159 | 232 | PDF p. 75 |
| – to subsidiaries and associatesmillion CHF | 65 | 66 | PDF p. 75 |
| Liabilities - Current liabilities | |||
| Total current liabilitiesmillion CHF | 1,960 | 2,453 | PDF p. 75 |
| Liabilities - Non-current liabilities - Long-term interest-bearing liabilities | |||
| – to third partiesmillion CHF | 0 | 180 | PDF p. 75 |
| – to subsidiaries and associatesmillion CHF | 3,825 | 4,005 | PDF p. 75 |
| Liabilities - Non-current liabilities - Long-term financial liabilities | |||
| – to third partiesmillion CHF | 75 | 107 | PDF p. 75 |
| Liabilities - Non-current liabilities - Long-term provisions | |||
| – to third partiesmillion CHF | 1 | 2 | PDF p. 75 |
| Liabilities - Non-current liabilities | |||
| Total non-current liabilitiesmillion CHF | 3,901 | 4,294 | PDF p. 75 |
| Liabilities | |||
| Total liabilitiesmillion CHF | 5,861 | 6,747 | PDF p. 75 |
| Shareholders' equity | |||
| Share capitalmillion CHF | 70 | 72 | PDF p. 75 |
| Shareholders' equity - Legal capital reserves | |||
| – Reserves from capital contributionsmillion CHF | 942 | 1,584 | PDF p. 75 |
| Shareholders' equity - Legal retained earnings reserves | |||
| – General legal retained earnings in the narrower sensemillion CHF | 37 | 37 | PDF p. 75 |
| Shareholders' equity - Voluntary retained earnings - Available earnings | |||
| – Profit brought forwardmillion CHF | 5,796 | 6,565 | PDF p. 75 |
| – Dividend paidmillion CHF | (140) | (143) | PDF p. 75 |
| – Share cancelationmillion CHF | (502) | (496) | PDF p. 75 |
| – (Loss) for the yearmillion CHF | (1,181) | (131) | PDF p. 75 |
| Shareholders' equity - Treasury shares | |||
| – Against reserves from capital contributionsmillion CHF | 0 | (362) | PDF p. 75 |
| – Against voluntary retained earnings or for share plansmillion CHF | (220) | (410) | PDF p. 75 |
| Shareholders' equity | |||
| Total shareholders’ equitymillion CHF | 4,802 | 6,716 | PDF p. 75 |
| Liabilities and Shareholders' equity | |||
| Total liabilities and shareholders’ equitymillion CHF | 10,663 | 13,463 | PDF p. 75 |
Original report: PDF p. 75 ↗
At 31 December.
Total assets exact amounts: 2025 CHF 10,663,388,887; 2024 CHF 13,463,395,048.
Treasury shares exact amounts: 2025 CHF 220,173,391; 2024 CHF 773,539,423.
Assets and Liabilities/Equity panels are printed side by side on the page; 'from/to third parties' and 'from/to subsidiaries and associates' are sub-lines under the listed headings.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group, million CHF | 2024Group, million CHF | Source |
|---|---|---|---|
| Profit | |||
| Profit / (Loss) for the periodmillion CHF | (275) | 637 | PDF p. 34 |
| Items that will not be reclassified to profit or loss | |||
| Remeasurements of net defined benefit liabilitymillion CHF | 139 | (34) | PDF p. 34 |
| Income tax on items that will not be reclassified to profit or lossmillion CHF | (22) | 5 | PDF p. 34 |
| Items that are or may be reclassified subsequently to profit or loss | |||
| Exchange differences on translating foreign operationsmillion CHF | (555) | 298 | PDF p. 34 |
| Cash flow hedges – effective portion of changes in fair valuemillion CHF | 89 | (105) | PDF p. 34 |
| Cash flow hedges – reclassified to property, plant and equipmentmillion CHF | 6 | 8 | PDF p. 34 |
| Cash flow hedges – reclassified to goodwillmillion CHF | 0 | 35 | PDF p. 34 |
| Cash flow hedges – reclassified to profit or lossmillion CHF | (35) | 32 | PDF p. 34 |
| Cash flow hedges – costs of hedgingmillion CHF | (46) | (29) | PDF p. 34 |
| Income tax on items that are or may be reclassified to profit or lossmillion CHF | 10 | (10) | PDF p. 34 |
| Other comprehensive income | |||
| Other comprehensive income for the period, net of taxmillion CHF | (414) | 200 | PDF p. 34 |
| Total | |||
| Total other comprehensive income for the periodmillion CHF | (689) | 837 | PDF p. 34 |
| Total comprehensive income attributable to | |||
| Equity holders of the parentmillion CHF | (684) | 834 | PDF p. 34 |
| Non-controlling interestsmillion CHF | (5) | 3 | PDF p. 34 |
| Total comprehensive income for the periodmillion CHF | (689) | 837 | PDF p. 34 |
Original report: PDF p. 34 ↗
For the year ended 31 December.
See the accompanying notes to the consolidated financial statements.
Subtotals 117/(29) and (531)/229 are printed on the income tax lines in the source.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group, million CHF | 2024Group, million CHF | Source |
|---|---|---|---|
| Operating activities | |||
| Profit / (Loss) for the periodmillion CHF | (275) | 637 | PDF p. 35 |
| Operating activities - adjustments for non-cash items | |||
| – Income taxesmillion CHF | 196 | 117 | PDF p. 35 |
| – Net financial resultmillion CHF | 150 | 209 | PDF p. 35 |
| – Share of loss / (profit) of associates / joint venturesmillion CHF | (2) | 1 | PDF p. 35 |
| – Depreciation of property, plant and equipment (incl. depreciation of right-of-use assets)million CHF | 620 | 472 | PDF p. 35 |
| – Amortization of intangiblesmillion CHF | 193 | 175 | PDF p. 35 |
| – Reversal of impairmentmillion CHF | (13) | (21) | PDF p. 35 |
| – Goodwill impairmentmillion CHF | 1,229 | 16 | PDF p. 35 |
| – Increase / (decrease) in provisionsmillion CHF | 66 | 108 | PDF p. 35 |
| – Non-cash items related to businesses combinationsmillion CHF | (3) | 8 | PDF p. 35 |
| – One-time positive financial impact from lease terminations of sites closuresmillion CHF | (14) | 0 | PDF p. 35 |
| – Amortization of other liabilities / assetsmillion CHF | (478) | (204) | PDF p. 35 |
| – Share-based paymentsmillion CHF | 57 | 41 | PDF p. 35 |
| Operating activities | |||
| Income taxes paidmillion CHF | (136) | (136) | PDF p. 35 |
| Interest paidmillion CHF | (164) | (99) | PDF p. 35 |
| Total before change in net working capitalmillion CHF | 1,540 | 1,474 | PDF p. 35 |
| Decrease / (increase) in inventoriesmillion CHF | (298) | 0 | PDF p. 35 |
| Decrease / (increase) in trade receivablesmillion CHF | (33) | (108) | PDF p. 35 |
| Increase / (decrease) in trade payablesmillion CHF | 118 | 3 | PDF p. 35 |
| (Increase) / decrease other net working capitalmillion CHF | (76) | 46 | PDF p. 35 |
| Use of provisionsmillion CHF | (55) | (45) | PDF p. 35 |
| Increase / (decrease) in other payables, netmillion CHF | (40) | (96) | PDF p. 35 |
| Net cash provided by / (used for) operating activitiesmillion CHF | 1,156 | 1,274 | PDF p. 35 |
| Investing activities | |||
| Purchase of property, plant and equipmentmillion CHF | (1,321) | (1,381) | PDF p. 35 |
| Purchase of intangible assetsmillion CHF | (52) | (36) | PDF p. 35 |
| Proceeds from sale of tangible and intangible assetsmillion CHF | 106 | 5 | PDF p. 35 |
| Acquisitions of subsidiaries, net of cash acquiredmillion CHF | (56) | (1,075) | PDF p. 35 |
| Purchase of unconsolidated investmentsmillion CHF | (3) | (4) | PDF p. 35 |
| Lease payments receivedmillion CHF | 3 | 3 | PDF p. 35 |
| Decrease / (increase) in capitalized contract assetsmillion CHF | (5) | (55) | PDF p. 35 |
| Net proceeds from disposals and purchases of other assetsmillion CHF | (2) | (1) | PDF p. 35 |
| Net proceeds from disposals and purchases of short-term investmentsmillion CHF | 600 | (400) | PDF p. 35 |
| Net proceeds from issuance and repayments of loansmillion CHF | (1) | (7) | PDF p. 35 |
| Interest receivedmillion CHF | 13 | 33 | PDF p. 35 |
| Dividends receivedmillion CHF | 0 | 2 | PDF p. 35 |
| Net cash provided by / (used for) investing activitiesmillion CHF | (718) | (2,916) | PDF p. 35 |
| Financing activities | |||
| Repayment of straight bondsmillion CHF | 0 | (110) | PDF p. 35 |
| Repayment of bank loanmillion CHF | (398) | 0 | PDF p. 35 |
| Repayment of German Private Placementsmillion CHF | 0 | (43) | PDF p. 35 |
| Issuance of straight bondsmillion CHF | 0 | 2,071 | PDF p. 35 |
| Increase / (decrease) in other debtmillion CHF | (15) | (41) | PDF p. 35 |
| Repayment of lease liabilitiesmillion CHF | (41) | (41) | PDF p. 35 |
| Increase in other non-current liabilitiesmillion CHF | 487 | 452 | PDF p. 35 |
| Purchase of treasury sharesmillion CHF | (518) | (726) | PDF p. 35 |
| Sale of treasury sharesmillion CHF | 11 | 9 | PDF p. 35 |
| Dividends paidmillion CHF | (282) | (288) | PDF p. 35 |
| Net cash provided by / (used for) financing activitiesmillion CHF | (756) | 1,283 | PDF p. 35 |
| Cash and cash equivalents | |||
| Effect of currency translation on cashmillion CHF | (8) | 2 | PDF p. 35 |
| Net increase / (decrease) in cash and cash equivalentsmillion CHF | (326) | (357) | PDF p. 35 |
| Cash and cash equivalents at 1 Januarymillion CHF | 1,111 | 1,468 | PDF p. 35 |
| Cash and cash equivalents at 31 Decembermillion CHF | 785 | 1,111 | PDF p. 35 |
| Cash and cash equivalents classified as held for salemillion CHF | (66) | 0 | PDF p. 35 |
| Cash and cash equivalents at 31 December (as reported)million CHF | 719 | 1,111 | PDF p. 35 |
Original report: PDF p. 35 ↗
For the year ended 31 December.
See the accompanying notes to the consolidated financial statements.
Purchase of treasury shares includes the effects from the Share Buyback Program that was initiated in 2023.
Dividends paid includes dividends of CHF 2 million (2024: CHF 3 million) paid to non-controlling interest shareholders of a subsidiary.
Rows for 'Increase / (decrease) in employee benefit liability' and '(Gain) / loss on disposal of property, plant and equipment' have values printed without clear alignment; they are not extracted individually.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2024Group, Share capital, million CHF | 2024Group, Share premium, million CHF | 2024Group, Retained earnings, million CHF | 2024Group, Hedging reserve, million CHF | 2024Group, Translation reserve, million CHF | 2024Group, Treasury shares, million CHF | 2024Group, Total attributable to equity holders of the parent, million CHF | 2024Group, Non-controlling interests, million CHF | 2024Group, Total equity, million CHF | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| Opening balance | ||||||||||
| At 1 January 2024million CHF | 74 | 2,452 | 9,486 | (23) | (1,479) | (1,058) | 9,452 | 60 | 9,512 | PDF p. 36 |
| 2024 movements | ||||||||||
| Profit for the periodmillion CHF | 0 | 0 | 636 | 0 | 0 | 0 | 636 | 1 | 637 | PDF p. 36 |
| - Remeasurement of defined benefit liabilitymillion CHF | 0 | 0 | (29) | 0 | 0 | 0 | (29) | 0 | (29) | PDF p. 36 |
| - Exchange differences on translating foreign operationsmillion CHF | 0 | 0 | 0 | 0 | 286 | 0 | 286 | 2 | 288 | PDF p. 36 |
| - Cash flow hedgesmillion CHF | 0 | 0 | 0 | (59) | 0 | 0 | (59) | 0 | (59) | PDF p. 36 |
| Other comprehensive income, net of taxmillion CHF | 0 | 0 | (29) | (59) | 286 | 0 | 198 | 2 | 200 | PDF p. 36 |
| Total comprehensive income for the periodmillion CHF | 0 | 0 | 607 | (59) | 286 | 0 | 834 | 3 | 837 | PDF p. 36 |
| Dividendsmillion CHF | 0 | (142) | (143) | 0 | 0 | 0 | (285) | (3) | (288) | PDF p. 36 |
| Recognition of share-based paymentsmillion CHF | 0 | 0 | 43 | 0 | 0 | 0 | 43 | 0 | 43 | PDF p. 36 |
| Movements in treasury sharesmillion CHF | 0 | 0 | (5) | 0 | 0 | (711) | (716) | 0 | (716) | PDF p. 36 |
| Capital reductionmillion CHF | (2) | (497) | (497) | 0 | 0 | 996 | 0 | 0 | 0 | PDF p. 36 |
| Closing balance | ||||||||||
| At 31 December 2024million CHF | 72 | 1,813 | 9,491 | (82) | (1,193) | (773) | 9,328 | 60 | 9,388 | PDF p. 36 |
Original report: PDF p. 36 ↗
Attributable to equity holders of the parent (first seven columns); Non-controlling interests and Total equity follow.
Opening balance is at 1 January 2024; closing at 31 December 2024.
Only Group-level statement presented; no separate Company statement of changes in equity within these pages.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group, Share capital, million CHF | 2025Group, Share premium, million CHF | 2025Group, Retained earnings, million CHF | 2025Group, Hedging reserve, million CHF | 2025Group, Translation reserve, million CHF | 2025Group, Treasury shares, million CHF | 2025Group, Total attributable to equity holders of the parent, million CHF | 2025Group, Non-controlling interests, million CHF | 2025Group, Total equity, million CHF | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| Opening balance | ||||||||||
| At 31 December 2024million CHF | 72 | 1,813 | 9,491 | (82) | (1,193) | (773) | 9,328 | 60 | 9,388 | PDF p. 36 |
| 2025 movements | ||||||||||
| Profit / (Loss) for the periodmillion CHF | 0 | 0 | (275) | 0 | 0 | 0 | (275) | 0 | (275) | PDF p. 36 |
| - Remeasurement of defined benefit liabilitymillion CHF | 0 | 0 | 117 | 0 | 0 | 0 | 117 | 0 | 117 | PDF p. 36 |
| - Exchange differences on translating foreign operationsmillion CHF | 0 | 0 | 0 | 0 | (540) | 0 | (540) | (5) | (545) | PDF p. 36 |
| - Cash flow hedgesmillion CHF | 0 | 0 | 0 | 14 | 0 | 0 | 14 | 0 | 14 | PDF p. 36 |
| Other comprehensive income, net of taxmillion CHF | 0 | 0 | 117 | 14 | (540) | 0 | (409) | (5) | (414) | PDF p. 36 |
| Total comprehensive income for the periodmillion CHF | 0 | 0 | (158) | 14 | (540) | 0 | (684) | (5) | (689) | PDF p. 36 |
| Dividendsmillion CHF | 0 | (140) | (140) | 0 | 0 | 0 | (280) | (2) | (282) | PDF p. 36 |
| Recognition of share-based paymentsmillion CHF | 0 | 0 | 56 | 0 | 0 | 0 | 56 | 0 | 56 | PDF p. 36 |
| Movements in treasury sharesmillion CHF | 0 | 0 | (54) | 0 | 0 | (453) | (507) | 0 | (507) | PDF p. 36 |
| Capital reductionmillion CHF | (2) | (502) | (502) | 0 | 0 | 1,006 | 0 | 0 | 0 | PDF p. 36 |
| Closing balance | ||||||||||
| At 31 December 2025million CHF | 70 | 1,171 | 8,693 | (68) | (1,733) | (220) | 7,913 | 53 | 7,966 | PDF p. 36 |
Original report: PDF p. 36 ↗
Opening balance is At 31 December 2024; closing is At 31 December 2025.
Capital reduction row carries note reference 25.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2016Group (2016 incl. Water Care and Specialty Ingredients) | 2017Group (incl. Water Care until 2017) | 2018Group (excl. Water Care; incl. Specialty Ingredients) | 2019Group (excl. Specialty Ingredients) | 2020Group | 2021Group | 2022Group | 2023Group (incl. Capsules & Health Ingredients) | 2024Restated, excl. Capsules & Health Ingredients (continuing operations) | 2025Continuing operations excl. Capsules & Health Ingredients | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ten-Year Overview | |||||||||||
| Salesmillion CHF | 4,132 | 4,548 | 5,542 | 4,207 | 4,508 | 5,409 | 6,223 | 6,717 | 5,480 | 6,531 | PDF p. 10 |
| CORE EBITDA 1million CHF | 918 | 1,196 | 1,511 | 1,334 | 1,379 | 1,665 | 1,995 | 1,999 | 1,653 | 2,064 | PDF p. 10 |
| Margin in %% | 22.2 | 26.5 | 27.3 | 31.7 | 30.6 | 30.8 | 32.1 | 29.8 | 30.2 | 31.6 | PDF p. 10 |
| EBITDAmillion CHF | 848 | 1,084 | 1,429 | 1,264 | 1,378 | 1,365 | 2,139 | 1,940 | 1,452 | 1,970 | PDF p. 10 |
| CORE EPS in CHFCHF | 7.81 | 10.87 | 12.03 | 13.67 | 11.73 | 14.36 | 16.30 | 13.89 | 13.12 | 15.08 | PDF p. 10 |
| EPS in CHFCHF | 5.31 | 9.78 | 8.80 | 10.28 | 9.81 | 9.08 | 16.37 | 8.88 | 8.51 | 13.04 | PDF p. 10 |
| Operational free cash flowmillion CHF | 638 | 658 | 884 | 371 | 504 | 412 | (420) | 374 | 473 | 674 | PDF p. 10 |
| Net debt / (net cash) 5million CHF | 1,584 | 3,762 | 3,534 | 2,961 | 2,813 | (958) | (186) | 922 | 2,859 | 3,258 | PDF p. 10 |
| Net debt / CORE EBITDA 5ratio (x) | 1.7 | 2.7 | 2.3 | 1.8 | 1.7 | (0.6) | (0.1) | 0.5 | 1.7 | 1.6 | PDF p. 10 |
| Number of employeesFTE | 10,130 | 14,618 | 15,375 | 15,468 | 14,062 | 16,218 | 17,494 | 18,000 | 15,734 | 16,866 | PDF p. 10 |
Original report: PDF p. 10 ↗
(bef. acquisitions and divestitures) qualifies Operational free cash flow.
1 Refer to section "Alternative Performance Measures" of the Financial Report for more details on the calculation methodology.
2 Until 2017, Lonza including the Water Care business. From 2018, Lonza excluding the Water Care business.
3 Until 2018, Lonza including the Specialty Ingredients business (reported as discontinued operations until effective disposal 1 July 2021). From 2019, Lonza excluding the Specialty Ingredients business.
4 CORE results for the Full-year 2020 (CORE EBITDA, ROIC, CORE EPS) were restated to reflect the changes from the revised Alternative Performance Measures policy that was introduced on 1 January 2021.
5 "Net debt", "Net debt / CORE EBITDA" reflect total group including discontinued operations. For 2021 and 2022, financials were reflected based on Lonza continuing operations basis (excluding Lonza Specialty Ingredients business).
6 In 2024, Lonza revised the definitions of several Performance Measures. As a result, the Operational Free Cash Flow and CORE EPS were restated for 2021, 2022 and 2023.
7 Restated to reflect the classification of the Capsules & Health Ingredients business as discontinued operations (see note 4). Until 2023, Lonza including Capsules & Health Ingredients business. From 2024, Lonza excluding Capsules & Health Ingredients business.
Footnote markers printed inside rows (e.g. '4', '6') are footnote references, not values.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Single value column; fiscal year is given by the row label (2015 to 2025) | Source |
|---|---|---|
| Dividend Payment History | ||
| 2015CHF/Share | 2.50 | PDF p. 9 |
| 2016CHF/Share | 2.75 | PDF p. 9 |
| 2017CHF/Share | 2.75 | PDF p. 9 |
| 2018CHF/Share | 2.75 | PDF p. 9 |
| 2019CHF/Share | 2.75 | PDF p. 9 |
| 2020CHF/Share | 3.00 | PDF p. 9 |
| 2021CHF/Share | 3.00 | PDF p. 9 |
| 2022CHF/Share | 3.50 | PDF p. 9 |
| 2023CHF/Share | 4.00 | PDF p. 9 |
| 2024CHF/Share | 4.00 | PDF p. 9 |
Original report: PDF p. 9 ↗
1 The overview shows the dividend declared for the respective fiscal year.
2 Proposed.
Text: Board will propose to increase the dividend by +25% to CHF 5.00 per share at the AGM in May 2026; payout of 38.5% based on profit for the period of Lonza Group continuing operations; 50% to be paid out of the capital contribution reserve.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group | 2024Group | Source |
|---|---|---|---|
| Weighted average number of outstanding shares (basic) | |||
| Weighted average number of outstanding sharesshares | 70,022,180 | 71,175,084 | PDF p. 58 |
| Weighted average number of outstanding shares (diluted) | |||
| – Adjustments for dilutive share units and sharesshares | 212,712 | 118,364 | PDF p. 58 |
| Weighted average number of shares for diluted earnings per shareshares | 70,234,892 | 71,293,448 | PDF p. 58 |
Original report: PDF p. 58 ↗
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Continuing operations | 2025Discontinued operations | 2025Total | 2024Continuing operations | 2024Discontinued operations | 2024Total | Source |
|---|---|---|---|---|---|---|---|
| Note 26 | |||||||
| Profit / (Loss) for the period (equity holders of the parent)million CHF | 913 | (1,188) | (275) | 606 | 30 | 636 | PDF p. 58 |
Original report: PDF p. 58 ↗
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group | 2024Group | Source |
|---|---|---|---|
| Note 26 | |||
| Dividend paid for the period 1million CHF | 280 | 285 | PDF p. 58 |
| Dividends declared after the balance sheet datemillion CHF | 349 | 283 | PDF p. 58 |
Original report: PDF p. 58 ↗
1 Excluding dividends of CHF 2 million (2024: CHF 3 million) paid to minority shareholders of a subsidiary.
Units appear below each metric. Scroll to compare years
| Metric / unit | 202531 December 2025 | 202431 December 2024 | 2025Change, 31 December 2025 vs 31 December 2024 | Source |
|---|---|---|---|---|
| Components of net debt / (net cash) | ||||
| Total debtmillion CHF | 4,185 | 4,710 | (525) | PDF p. 84 |
| Net debt / (net cash)million CHF | 3,258 | 2,859 | 399 | PDF p. 84 |
Original report: PDF p. 84 ↗
1 Liquidity and Capital Measures considers consolidated Lonza Group results, incl. Discontinued Operations.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Continuing operations, twelve months ended 31 December 2025 | 2024Restated, twelve months ended 31 December 2024 | Source |
|---|---|---|---|
| ROIC | |||
| Net operating profit after taxes (NOPAT)million CHF | 1,146 | 981 | PDF p. 84 |
| Average invested capitalmillion CHF | 9,625 | 9,008 | PDF p. 84 |
| ROIC in %% | 11.9 | 10.9 | PDF p. 84 |
Original report: PDF p. 84 ↗
1 Restated to reflect the classification of the Capsule and Health Ingredients business as discontinued operations (see note 33). Lonza defines ROIC as NOPAT divided by the average invested capital of the Group.
Group tax rate on continuing business of 17.4% (2024: 15.0%).
Where the money comes from
| Item / unit | 2025Integrated Biologics | 2025Advanced Synthesis | 2025Specialized Modalities | 2025Total operating segments | 2025Corporate / Eliminations | 2025Lonza Continuing Business | Source |
|---|---|---|---|---|---|---|---|
| Segment revenue | |||||||
| Sales third-partymillion CHF | 3,649 | 1,611 | 1,034 | 6,294 | 237 | 6,531 | PDF p. 38 |
| Inter-segment sales 1million CHF | 5 | 6 | 66 | 77 | (77) | 0 | PDF p. 38 |
| Total salesmillion CHF | 3,654 | 1,617 | 1,100 | 6,371 | 160 | 6,531 | PDF p. 38 |
| Segment result | |||||||
| CORE EBITDA 2million CHF | 1,287 | 674 | 176 | 2,137 | (73) | 2,064 | PDF p. 38 |
| Included in CORE EBITDA | |||||||
| Research and development 3million CHF | (111) | (13) | (41) | (165) | (4) | (169) | PDF p. 38 |
| Depreciation and amortizationmillion CHF | (331) | (153) | (134) | (618) | (28) | (646) | PDF p. 38 |
| Impairment, net of reversal of impairment 4million CHF | (14) | (19) | (59) | (92) | 7 | (85) | PDF p. 38 |
| Restructuring income / (expenses)million CHF | (4) | 0 | (2) | (6) | 0 | (6) | PDF p. 38 |
| Environmental expenses, net of reversalmillion CHF | 0 | 0 | 0 | 0 | (42) | (42) | PDF p. 38 |
| Other segment information | |||||||
| Additions to property, plant and equipmentmillion CHF | 451 | 305 | 358 | 1,114 | 163 | 1,277 | PDF p. 38 |
Continuing business after classification of Capsules & Health Ingredients as discontinued operations (note 4). Intersegment sales were based on prevailing market prices. CORE EBITDA per Alternative Performance Measures. Impairment footnote 4: Includes reversal of impairment in Corporate of CHF 9 million and in Integrated Biologics of CHF 2 million. R&D refer to note 22.
| Item / unit | 2024Integrated Biologics (restated) | 2024Advanced Synthesis (restated) | 2024Specialized Modalities (restated) | 2024Total operating segments (restated) | 2024Corporate / Eliminations (restated) | 2024Lonza Continuing Business (restated) | Source |
|---|---|---|---|---|---|---|---|
| Segment revenue | |||||||
| Sales third-partymillion CHF | 2,883 | 1,323 | 1,099 | 5,305 | 175 | 5,480 | PDF p. 38 |
| Inter-segment sales 2million CHF | 10 | 3 | 56 | 69 | (69) | 0 | PDF p. 38 |
| Total salesmillion CHF | 2,893 | 1,326 | 1,155 | 5,374 | 106 | 5,480 | PDF p. 38 |
| Segment result | |||||||
| CORE EBITDA 3million CHF | 1,045 | 484 | 192 | 1,721 | (68) | 1,653 | PDF p. 38 |
| Included in CORE EBITDA | |||||||
| Research and development 4million CHF | (99) | (32) | (82) | (213) | (5) | (218) | PDF p. 38 |
| Depreciation and amortizationmillion CHF | (216) | (105) | (120) | (441) | (32) | (473) | PDF p. 38 |
| Impairment, net of reversal of impairment 5million CHF | (7) | (17) | (16) | (40) | (31) | (71) | PDF p. 38 |
| Restructuring income / (expenses)million CHF | (194) | 0 | (2) | (196) | 0 | (196) | PDF p. 38 |
| Capitalized contract costs write-offmillion CHF | (145) | 0 | 0 | (145) | 0 | (145) | PDF p. 38 |
| Environmental expenses, net of reversalmillion CHF | 0 | 0 | 0 | 0 | (80) | (80) | PDF p. 38 |
| Other segment information | |||||||
| Additions to property, plant and equipmentmillion CHF | 604 | 274 | 253 | 1,131 | 162 | 1,293 | PDF p. 38 |
| Additions to property, plant and equipment from acquisitionsmillion CHF | 706 | 0 | 0 | 706 | 0 | 706 | PDF p. 38 |
| Additions to intangible assetsmillion CHF | 3 | 0 | 9 | 12 | 16 | 28 | PDF p. 38 |
Restated to reflect classification of Capsules & Health Ingredients as discontinued operations (note 4). Intersegment sales based on prevailing market prices. Impairment footnote 5: Includes reversal of impairment in Specialized Modalities of CHF 21 million related to Singapore.
| Item / unit | 2025Revenue from external customers (sales) | 2025Property, plant and equipment | 2025Intangible assets | 2025Goodwill | 2025Other non-current assets | 2025Total non-current assets (excludes deferred tax assets) | Source |
|---|---|---|---|---|---|---|---|
| Europe | |||||||
| Belgiummillion CHF | 470 | 33 | 2 | 1,092 | 0 | 1,127 | PDF p. 39 |
| Czech Republicmillion CHF | 4 | 0 | 0 | 0 | 0 | 0 | PDF p. 39 |
| Denmarkmillion CHF | 235 | 0 | 0 | 0 | 0 | 0 | PDF p. 39 |
| Francemillion CHF | 42 | 0 | 0 | 8 | 1 | 9 | PDF p. 39 |
| Germanymillion CHF | 241 | 17 | 6 | 54 | 0 | 77 | PDF p. 39 |
| Irelandmillion CHF | 398 | 0 | 0 | 0 | 0 | 0 | PDF p. 39 |
| Italymillion CHF | 29 | 1 | 0 | 1 | 0 | 2 | PDF p. 39 |
| Netherlandsmillion CHF | 233 | 133 | 65 | 82 | 2 | 282 | PDF p. 39 |
| Spainmillion CHF | 15 | 120 | 1 | 0 | 0 | 121 | PDF p. 39 |
| Swedenmillion CHF | 120 | 0 | 0 | 0 | 0 | 0 | PDF p. 39 |
| Switzerlandmillion CHF | 963 | 5,372 | 121 | 271 | 258 | 6,022 | PDF p. 39 |
| United Kingdommillion CHF | 212 | 178 | 2 | 7 | 0 | 187 | PDF p. 39 |
| Rest of Europemillion CHF | 32 | 0 | 0 | 0 | 0 | 0 | PDF p. 39 |
| Europe subtotal | |||||||
| Europemillion CHF | 2,994 | 5,854 | 197 | 1,515 | 261 | 7,827 | PDF p. 39 |
| North and Central America | |||||||
| Canadamillion CHF | 41 | 0 | 0 | 18 | 0 | 18 | PDF p. 39 |
| Mexicomillion CHF | 2 | 0 | 0 | 0 | 1 | 1 | PDF p. 39 |
| United Statesmillion CHF | 2,525 | 2,176 | 104 | 426 | 16 | 2,722 | PDF p. 39 |
| Rest of North and Central Americamillion CHF | 0 | 3 | 0 | 0 | 0 | 3 | PDF p. 39 |
| North and Central America subtotal | |||||||
| North and Central Americamillion CHF | 2,568 | 2,179 | 104 | 444 | 17 | 2,744 | PDF p. 39 |
| Latin America | |||||||
| Brazilmillion CHF | 5 | 0 | 0 | 0 | 0 | 0 | PDF p. 39 |
| Rest of Latin Americamillion CHF | 0 | 0 | 0 | 0 | 0 | 0 | PDF p. 39 |
| Latin America subtotal | |||||||
| Latin Americamillion CHF | 102 | 0 | 0 | 0 | 0 | 0 | PDF p. 39 |
| Asia | |||||||
| Chinamillion CHF | 77 | 62 | 1 | 0 | 0 | 63 | PDF p. 39 |
| Indiamillion CHF | 15 | 1 | 0 | 1 | 0 | 2 | PDF p. 39 |
| Indonesiamillion CHF | 0 | 0 | 0 | 0 | 0 | 0 | PDF p. 39 |
| Japanmillion CHF | 564 | 0 | 0 | 0 | 0 | 0 | PDF p. 39 |
| Singaporemillion CHF | 99 | 206 | 26 | 0 | 0 | 232 | PDF p. 39 |
| South Koreamillion CHF | 96 | 0 | 0 | 0 | 0 | 0 | PDF p. 39 |
| Thailandmillion CHF | 1 | 0 | 0 | 0 | 0 | 0 | PDF p. 39 |
| Rest of Asiamillion CHF | 8 | 2 | 0 | 0 | 0 | 2 | PDF p. 39 |
| Asia subtotal | |||||||
| Asiamillion CHF | 860 | 271 | 27 | 1 | 0 | 299 | PDF p. 39 |
| Other | |||||||
| Australia & New Zealandmillion CHF | 4 | 0 | 0 | 0 | 0 | 0 | PDF p. 39 |
| Other countriesmillion CHF | 3 | 0 | 0 | 0 | 0 | 0 | PDF p. 39 |
| Total | |||||||
| Total Lonzamillion CHF | 6,531 | 8,304 | 328 | 1,960 | 278 | 10,870 | PDF p. 39 |
Sales from external customers allocated to geographical areas by destination according to the location of the customer. Total non-current assets excludes deferred tax assets. Puerto Rico Total non-current assets cell is blank in the extracted text. Latin America total is printed as 0 for non-current columns.
| Item / unit | 2024Revenue from external customers (sales), restated | 2024Property, plant and equipment | 2024Intangible assets | 2024Goodwill | 2024Other non-current assets | 2024Total non-current assets (excludes deferred tax assets) | Source |
|---|---|---|---|---|---|---|---|
| Europe | |||||||
| Belgiummillion CHF | 447 | 34 | 0 | 1,101 | 0 | 1,135 | PDF p. 39 |
| Czech Republicmillion CHF | 4 | 0 | 0 | 0 | 0 | 0 | PDF p. 39 |
| Denmarkmillion CHF | 282 | 0 | 0 | 0 | 0 | 0 | PDF p. 39 |
| Francemillion CHF | 73 | 0 | 0 | 8 | 0 | 8 | PDF p. 39 |
| Germanymillion CHF | 231 | 18 | 8 | 55 | 0 | 81 | PDF p. 39 |
| Irelandmillion CHF | 420 | 0 | 0 | 0 | 0 | 0 | PDF p. 39 |
| Italymillion CHF | 34 | 1 | 0 | 1 | 0 | 2 | PDF p. 39 |
| Netherlandsmillion CHF | 161 | 134 | 68 | 82 | 3 | 287 | PDF p. 39 |
| Spainmillion CHF | 7 | 114 | 1 | 0 | 0 | 115 | PDF p. 39 |
| Swedenmillion CHF | 108 | 0 | 0 | 0 | 0 | 0 | PDF p. 39 |
| Switzerlandmillion CHF | 706 | 4,911 | 167 | 271 | 252 | 5,601 | PDF p. 39 |
| United Kingdommillion CHF | 221 | 201 | 2 | 7 | 0 | 210 | PDF p. 39 |
| Rest of Europemillion CHF | 38 | 0 | 0 | 0 | 0 | 0 | PDF p. 39 |
| Europe subtotal | |||||||
| Europemillion CHF | 2,732 | 5,413 | 246 | 1,525 | 255 | 7,439 | PDF p. 39 |
| North and Central America | |||||||
| Canadamillion CHF | 68 | 8 | 58 | 20 | 0 | 86 | PDF p. 39 |
| Mexicomillion CHF | 2 | 0 | 0 | 0 | 0 | 0 | PDF p. 39 |
| United Statesmillion CHF | 1,923 | 2,214 | 124 | 480 | 47 | 2,865 | PDF p. 39 |
| Rest of North and Central Americamillion CHF | 0 | 3 | 0 | 0 | 0 | 3 | PDF p. 39 |
| North and Central America subtotal | |||||||
| North and Central Americamillion CHF | 1,993 | 2,225 | 182 | 500 | 47 | 2,954 | PDF p. 39 |
| Latin America | |||||||
| Brazilmillion CHF | 11 | 0 | 0 | 0 | 0 | 0 | PDF p. 39 |
| Puerto Ricomillion CHF | 67 | 0 | 0 | 0 | 0 | 0 | PDF p. 39 |
| Rest of Latin Americamillion CHF | 0 | 0 | 0 | 0 | 0 | 0 | PDF p. 39 |
| Latin America subtotal | |||||||
| Latin Americamillion CHF | 78 | 0 | 0 | 0 | 0 | 0 | PDF p. 39 |
| Asia | |||||||
| Chinamillion CHF | 71 | 65 | 2 | 0 | 0 | 67 | PDF p. 39 |
| Indiamillion CHF | 13 | 1 | 0 | 1 | 0 | 2 | PDF p. 39 |
| Indonesiamillion CHF | 1 | 0 | 0 | 0 | 0 | 0 | PDF p. 39 |
| Japanmillion CHF | 432 | 0 | 0 | 0 | 0 | 0 | PDF p. 39 |
| Singaporemillion CHF | 31 | 247 | 34 | 0 | 0 | 281 | PDF p. 39 |
| South Koreamillion CHF | 115 | 0 | 0 | 0 | 0 | 0 | PDF p. 39 |
| Thailandmillion CHF | 2 | 0 | 0 | 0 | 0 | 0 | PDF p. 39 |
| Rest of Asiamillion CHF | 8 | 3 | 0 | 0 | 0 | 3 | PDF p. 39 |
| Asia subtotal | |||||||
| Asiamillion CHF | 673 | 316 | 36 | 1 | 0 | 353 | PDF p. 39 |
| Other | |||||||
| Australia & New Zealandmillion CHF | 4 | 0 | 0 | 1 | 0 | 1 | PDF p. 39 |
| Other countriesmillion CHF | 0 | 0 | 0 | 0 | 0 | 0 | PDF p. 39 |
| Total | |||||||
| Total Lonzamillion CHF | 5,480 | 7,954 | 464 | 2,027 | 302 | 10,747 | PDF p. 39 |
Restated to reflect classification of Capsules & Health Ingredients as discontinued operations (note 4). Sales allocated by destination per customer location. Total non-current assets excludes deferred tax assets. Below Total Lonza, printed reconciliation rows: Assets related to CHI discontinued operations 578, 1,538, 1,343, 34, 3,493 (5 values, column mapping not clearly printed) and Total Group 8,532, 2,002, 3,370, 336, 14,240; not tabulated due to column ambiguity.
Debt
| Item / unit | 2025Carrying amount | 2025Contractual cash flows incl. interest | 2025Between 0 and 6 months | 2025Between 7 and 12 months | 2025Between 1 and 2 years | 2025Between 2 and 3 years | 2025Between 3 and 5 years | 2025Over 5 years | 2024Carrying amount | 2024Contractual cash flows incl. interest | 2024Between 0 and 6 months | 2024Between 7 and 12 months | 2024Between 1 and 2 years | 2024Between 2 and 3 years | 2024Between 3 and 5 years | 2024Over 5 years | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt | |||||||||||||||||
| Straight bond (2020-2026)million CHF | 150 | 151 | 0 | 151 | 0 | 0 | 0 | 0 | 150 | 152 | 0 | 1 | 151 | 0 | 0 | 0 | PDF p. 60 |
| Straight bond (2023-2029)million CHF | 148 | 162 | 0 | 3 | 3 | 3 | 153 | 0 | 148 | 163 | 0 | 3 | 3 | 3 | 154 | 0 | PDF p. 60 |
| Straight bond (2023-2028)million CHF | 185 | 197 | 4 | 0 | 4 | 189 | 0 | 0 | 185 | 201 | 4 | 0 | 4 | 4 | 189 | 0 | PDF p. 60 |
| Straight bond (2023-2031)million CHF | 215 | 251 | 6 | 0 | 6 | 6 | 12 | 221 | 215 | 257 | 6 | 0 | 6 | 6 | 12 | 227 | PDF p. 60 |
| Euro bond (2020-2027)million CHF | 464 | 476 | 8 | 0 | 468 | 0 | 0 | 0 | 468 | 492 | 8 | 0 | 8 | 476 | 0 | 0 | PDF p. 60 |
| Euro bond (2023-2033)million CHF | 460 | 599 | 18 | 0 | 18 | 18 | 36 | 509 | 465 | 627 | 18 | 0 | 18 | 18 | 36 | 537 | PDF p. 60 |
| Euro bond (2024-2036)million CHF | 917 | 1,303 | 36 | 0 | 36 | 36 | 72 | 1,123 | 924 | 1,355 | 36 | 0 | 36 | 36 | 72 | 1,175 | PDF p. 60 |
| Euro bond (2024-2030)million CHF | 555 | 643 | 0 | 18 | 18 | 18 | 589 | 0 | 559 | 668 | 18 | 0 | 18 | 18 | 36 | 578 | PDF p. 60 |
| Euro bond (2024-2034)million CHF | 548 | 730 | 0 | 20 | 20 | 20 | 39 | 631 | 553 | 940 | 32 | 0 | 32 | 32 | 65 | 779 | PDF p. 60 |
| Term loanmillion CHF | 159 | 163 | 3 | 160 | 0 | 0 | 0 | 0 | 627 | 677 | 15 | 466 | 196 | 0 | 0 | 0 | PDF p. 60 |
| Other debt due to othersmillion CHF | 84 | 120 | 2 | 2 | 3 | 3 | 57 | 53 | 116 | 165 | 2 | 20 | 4 | 4 | 8 | 127 | PDF p. 60 |
| Total debtmillion CHF | 4,185 | 5,119 | 77 | 360 | 582 | 299 | 1,264 | 2,537 | 4,710 | 6,027 | 139 | 496 | 482 | 603 | 884 | 3,423 | PDF p. 60 |
| Other non-current liabilities | |||||||||||||||||
| – of which lease liabilitiesmillion CHF | 321 | 514 | 0 | 0 | 41 | 38 | 68 | 367 | 366 | 655 | 0 | 0 | 63 | 57 | 103 | 432 | PDF p. 60 |
| Other current liabilities | |||||||||||||||||
| – of which lease liabilitiesmillion CHF | 34 | 47 | 24 | 23 | 0 | 0 | 0 | 0 | 44 | 65 | 33 | 32 | 0 | 0 | 0 | 0 | PDF p. 60 |
1 Carrying amount of debt and financial liabilities excluding accrued interests.
2 Including interest payments.
Euro bond (2024-2030) and (2024-2034) rows as printed.
| Item / unit | 2025million CHF | 2024million CHF | Source |
|---|---|---|---|
| Non-Current Debt | |||
| Straight bondsmillion CHF | 3,792 | 3,967 | PDF p. 48 |
| Term loanmillion CHF | 0 | 177 | PDF p. 48 |
| Other long-term debtmillion CHF | 84 | 98 | PDF p. 48 |
| Total non-current debtmillion CHF | 3,876 | 4,242 | PDF p. 48 |
Carrying amount of debt excluding accrued interests (see note 15).
| Item / unit | 2025million CHF | 2024million CHF | Source |
|---|---|---|---|
| Current Debt | |||
| Term loanmillion CHF | 159 | 450 | PDF p. 48 |
| Othersmillion CHF | 0 | 18 | PDF p. 48 |
| Straight bond due within one year | |||
| – Straight bond (2020-2026)million CHF | 150 | 0 | PDF p. 48 |
| Current Debt | |||
| Total current debtmillion CHF | 309 | 468 | PDF p. 48 |
Carrying amount of debt excluding accrued interests (see note 15).
| Item / unit | 2025million CHF | 2024million CHF | Source |
|---|---|---|---|
| CHF bonds | |||
| 0.35%, CHF 150 million, 2020/2026, due 22 September 2026, issued at 100.148%million CHF | 150 | 150 | PDF p. 48 |
| 2.10%, CHF 300 million, 2023/2029, due 12 September 2029, issued at 100.241%million CHF | 300 | 300 | PDF p. 48 |
| 2.10%, CHF 150 million, 2023/2029, due 12 September 2029, issued at 98.961%million CHF | 148 | 148 | PDF p. 48 |
| 2.25%, CHF 185 million, 2023/2028, due 16 May 2028, issued at 100.054%million CHF | 185 | 185 | PDF p. 48 |
| 2.6%, CHF 215 million, 2023/2031, due 16 May 2031, issued at 100.295%million CHF | 215 | 215 | PDF p. 48 |
| EUR bonds | |||
| 1.625%, EUR 500 million, 2020/2027, due 21 April 2027, issued at 99.424%million CHF | 464 | 468 | PDF p. 48 |
| 3.875%, EUR 500 million, 2023/2033, due 25 May 2033, issued at 99.091%million CHF | 460 | 465 | PDF p. 48 |
| 3.875%, EUR 1,000 million, 2024/2036, due 24 April 2036, issued at 98.715%million CHF | 917 | 924 | PDF p. 48 |
| 3.25%, EUR 600 million, 2024/2030, due 4 September 2030, issued at 99.448%million CHF | 555 | 559 | PDF p. 48 |
| 3.5%, EUR 600 million, 2024/2034, due 4 September 2034, issued at 98.361%million CHF | 548 | 553 | PDF p. 48 |
| Straight bonds | |||
| Total including current portionmillion CHF | 3,942 | 3,967 | PDF p. 48 |
| Less current portion of straight bondsmillion CHF | (150) | 0 | PDF p. 48 |
| Total non-current straight bondsmillion CHF | 3,792 | 3,967 | PDF p. 48 |
| Item / unit | 2025million CHF | 2024million CHF | Source |
|---|---|---|---|
| Debt movements | |||
| At 1 Januarymillion CHF | 4,710 | 2,801 | PDF p. 48 |
| Repayment of straight bondmillion CHF | 0 | (110) | PDF p. 48 |
| Issuance of straight bondsmillion CHF | 0 | 2,071 | PDF p. 48 |
| Issuance / (repayment) of term loanmillion CHF | (398) | 0 | PDF p. 48 |
| Repayment of German Private Placementsmillion CHF | 0 | (43) | PDF p. 48 |
| (Decrease) / increase in other debtmillion CHF | (15) | (41) | PDF p. 48 |
| Changes from financing cash flowsmillion CHF | (413) | 1,877 | PDF p. 48 |
| Amortization of financing costs and discountsmillion CHF | 6 | 5 | PDF p. 48 |
| Net foreign currency transaction (gains) / lossesmillion CHF | (76) | 45 | PDF p. 48 |
| Currency translation effectsmillion CHF | (42) | (18) | PDF p. 48 |
| Changes in foreign exchanges ratesmillion CHF | (118) | 27 | PDF p. 48 |
| At 31 Decembermillion CHF | 4,185 | 4,710 | PDF p. 48 |
| Item / unit | 2025Average interest rate % | 2025% of total debt | 2025Amount, million CHF | 2024Average interest rate % | 2024% of total debt | 2024Amount, million CHF | Source |
|---|---|---|---|---|---|---|---|
| Total debt by currency | |||||||
| CHFmixed (% and million CHF) | 1.97 | 24 | 995 | 1.90 | 21 | 994 | PDF p. 49 |
| EURmixed (% and million CHF) | 3.34 | 70 | 2,944 | 2.61 | 63 | 2,969 | PDF p. 49 |
| USDmixed (% and million CHF) | 4.65 | 6 | 246 | 5.02 | 16 | 747 | PDF p. 49 |
Total row prints no average interest rate; values are % then amount for 2025 and 2024.
| Item / unit | 2025million CHF | 2024million CHF | Source |
|---|---|---|---|
| Other Non-Current Liabilities | |||
| Lease liabilitiesmillion CHF | 321 | 366 | PDF p. 49 |
| Other Current Liabilities | |||
| Lease liabilitiesmillion CHF | 34 | 44 | PDF p. 49 |
| Leases: movements in carrying value | |||
| At 1 Januarymillion CHF | 410 | 331 | PDF p. 49 |
| At 31 Decembermillion CHF | 355 | 410 | PDF p. 49 |
Payout
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Dividends per share declared after the balance sheet date in CHF | 5.00 CHF per share | FY2025 proposed dividend, declared after balance sheet date (2024 comparative: 4.00) | PDF p. 58 |
| Dividends per share for the period in CHF | 4.00 CHF per share | FY2024 dividend paid in 2025 (comparative 2024 column also 4.00 for FY2023) | PDF p. 58 |
| 2025 | 5.00 2 | Dividend declared for fiscal year 2025, CHF/share, proposed | PDF p. 9 |
| 2024 | 4.00 CHF per share | Dividend declared for fiscal year 2024, CHF/share | PDF p. 9 |
| Total proposed payment of a dividend | 349,221,146 CHF | FY2025 proposed total, based on share capital eligible for dividend of 69,844,229 at 31 December 2025 · As at 2025-12-31 | PDF p. 80 |
| Ex-Dividend Date | 12 May 2026 | FY2025 proposed dividend | PDF p. 10 |
| Record-Dividend Date | 13 May 2026 | FY2025 proposed dividend | PDF p. 10 |
| Dividend-Payment Date | 15 May 2026 | FY2025 proposed dividend | PDF p. 10 |
| Record-Dividend Date | 14.05.2025 | FY2024 dividend paid in 2025 | PDF p. 10 |
| Dividend-Payment Date | 15.05.2025 | FY2024 dividend paid in 2025 | PDF p. 10 |
| Dividend | CHF 4.00 per share | FY2024 dividend approved at AGM 9 May 2025 (FY2023: CHF 4.00) · As at 2025-05-09 | PDF p. 57 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| payout | 38.5% | FY2025 proposed dividend vs profit for the period of Lonza Group continuing operations | PDF p. 9 |
Extracted from Annual Report 2025 and checked against the cited pages; see the original report for full context.
Auditor’s report
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Deloitte AG | Deloitte AG | Group consolidated financial statements | PDF p. 72 |
| Fabien Lussu | Fabien Lussu | Group consolidated financial statements | PDF p. 74 |
| Opinion | give a true and fair view | Group consolidated financial statements | PDF p. 72 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Revenue Recognition – for Contract Manufacturing (Make-to-Order) | The Group’s recognition of make-to-order | Group consolidated financial statements | PDF p. 72 |
| Uncertain Income Tax Positions (UTP) and Related Tax Expenses | The Group operates across multiple jurisdictions | Group consolidated financial statements | PDF p. 73 |
| Assets held for sale and Discontinued operations | As part of its portfolio transformation to focus on | Group consolidated financial statements | PDF p. 73 |
Extracted from Annual Report 2025 and checked against the cited pages; see the original report for full context.
Group and parent company or bank figures are labelled separately. Parentheses indicate negative amounts; a dash and NA retain the report’s notation.
Comparative figures follow Annual Report 2025, including retrospective adjustments. Adjusted and reported earnings may have different definitions; refer to each statement’s notes.
These tables show the available extracted figures. The original annual report contains the full statements, notes and definitions.